Huaren Pharmaceutical Co., Ltd. (SHE:300110)

Huaren Pharmaceutical Revenue

Huaren Pharmaceutical had revenue of 268.92M CNY in the quarter ending September 30, 2026, a decrease of -23.68%. This brings the company's total for the last twelve months to 1.22B, down -2.92% year-over-year. In the year 2025, Huaren Pharmaceutical had annual revenue of 1.32B, down -2.34%. That makes Huaren Pharmaceutical the 18,132nd largest company in the world by revenue and 3,312th in China.

• Revenue (ttm): 1.22B
• Revenue Growth: -2.92%
• P/S Ratio: 2.53
• Revenue / Employee: 478.29K
• Employees: 2,549
• Market Cap: 3.09B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Industrial 1.23B 93.1%
• Business 91.23M 6.9%

Fiscal year ended Dec 31, 2025 See the full Huaren Pharmaceutical breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	1.32B	-31.71M	-2.34%
Dec 31, 2024	1.35B	-283.09M	-17.30%
Dec 31, 2023	1.64B	16.76M	1.04%
Jan 1, 2023	1.62B	58.64M	3.76%
Jan 1, 2022	1.56B	244.26M	18.55%

Data Source: S&P Global Market Intelligence Last updated: Oct 27, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 8, 2026

Data Sources Report a data error